Taylor Ben R 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Taylor Ben R（CIK 1712276）在 1 家公司共报告 20 笔 SEC Form 4 内部人交易（最近一笔 2026-09-16）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-16 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 卖出 | 5,396 | $18,400 |
| 2026-08-18 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 卖出 | 25,018 | $79,057 |
| 2026-06-17 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 卖出 | 5,396 | $16,997 |
| 2026-05-19 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 卖出 | 25,018 | $76,055 |
| 2026-04-08 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 卖出 | 48,028 | $149,367 |
| 2026-03-18 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 卖出 | 7,075 | $24,196 |
| 2026-03-18 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 卖出 | 7,956 | $26,971 |
| 2026-02-19 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 卖出 | 11,908 | $41,559 |
| 2026-02-19 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 卖出 | 13,426 | $41,352 |
| 2026-02-10 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 买入 | 446,279 | $0 |
| 2026-02-10 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 买入 | 24,254 | $0 |
| 2026-02-10 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 卖出 | 11,400 | $45,372 |
| 2025-12-30 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 卖出 | 21,383 | $89,381 |
| 2025-12-17 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 卖出 | 7,057 | $30,557 |
| 2025-11-26 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 卖出 | 2,271 | $9,152 |
| 2025-11-19 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 卖出 | 11,908 | $49,299 |
| 2025-09-17 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 卖出 | 7,057 | $34,085 |
| 2025-08-19 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 卖出 | 11,908 | $67,161 |
| 2025-06-18 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 卖出 | 7,057 | $34,720 |
| 2025-05-19 | RECURSION PHARMACEUTICALS, INC. (RXRX) | Chief Financial Officer | 卖出 | 11,908 | $50,609 |
来源：SEC Form 4 申报文件 · 截至 2026-09-16